Becton, Dickinson and Company (NYSE:BDX) shareholders approved all four proposals presented at the company’s annual meeting, ...

BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue removal system.

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the global commercial launch of BD Research Cloud 7.0, marking another step forward in its AI-driven life sciences strategy ...

BD and Envetec prove medical plastic waste can be safely recycled into new products reducing landfill dependency ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...

Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available to healthcare providers after years of development.

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters. As part of a $10 million investment in 2024, new ...

Earlier this year, BD revealed its intent to split from its lifesciences and diagnostic solutions business to become a pure-play medical device company. On the surface, medtech analysts have largely ...

A growing number of financial advisors have been leaving their broker-dealer (BD) firms to start or join a registered investment advisor (RIA), an annual industry analysis has found. The study noted ...